Pain and opioids;Fájdalom és opioidok

Orvosi Hetilap

Volumn 149, Issue 50, 2008, Pages 2363-2370

  Murányi, Marianna ^a,b   Radák, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Analgesy; Opioids; Pain

Indexed keywords

ANALGESIC AGENT; BETA ENDORPHIN; DELTORPHIN; DYNORPHIN; DYNORPHIN A; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; LEUCINE ENKEPHALIN; METENKEPHALIN; MORPHINE; NALOXAZONE; NALOXONE; NALTRINDOLE; NONSTEROID ANTIINFLAMMATORY AGENT; NORBINALTORPHIMINE; OPIATE DERIVATIVE; OPIATE RECEPTOR;

ANALGESIA; CANCER PAIN; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; DRUG DESIGN; DRUG EFFECT; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERANCE; DRUG USE; EMOTIONALITY; EUPHORIA; HUNGARY; INTESTINE INNERVATION; MOTOR PERFORMANCE; NEUROPATHIC PAIN; NOCICEPTIVE RECEPTOR; NOCICEPTIVE STIMULATION; OPIATE ADDICTION; PAIN; POSTOPERATIVE PAIN; REVIEW;

EID: 58349093758     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28449     Document Type: Review

References (36)

1. Meyr, A. J., Steinberg, J. S.: The physiology of the acute pain pathway. Clin. Podiatr. Med. Surg., 2008, 25, 305-326.
2. Galuzzi, K. E.: Managing neuropathic pain. JAOA, 2007, 6, 39-48.
3. Giordano, J.: The neurobiology of nociceptive and anti-nociceptive systems. Pain Phys., 2005, 8, 277-290.
4. Palkovits M.: Az agy és a fájdalom: az érzékelés és a válasz agypályái és transzmitterei. Orv. Hetil., 2000, 141, 2251-2240.
5. Cao, Y., Mantyh, P., Carlson, E. és mtsai: Primary afferent tachykinins are required to experience moderate to intense pain. Nature, 1998, 392, 390-394.
6. Dubner, R., Bennett, G.: Spinal and trigeminal mechanisms of nociception. Annu. Rev. Neurosci., 1983, 6, 381-418.
7. Fields, H., Heinricher, M. M., Mason, P.: Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci., 1991, 14, 219-245.
8. Kalyuzhny, A. E., Wessendorf, M. W.: Relationship of mu and delta opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. J. Comp. Neurol., 1998, 392, 528-547.
9. Basbaum, A., Fields, H.: The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: futher studies of the anatomy of pain modulation. J. Comp. Neurol., 1979, 187, 513-531.
10. Nersesyan, H., Slavin, K. V.: Current approach to cancer pain management: availability and implications of different treatment options. Ther. Clin. Risk Manag., 2007, 3, 381-400.
11. Head, K. A.: Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Alternative Med. Rev., 2006, 11, 294-329.
12. Dhond, R. P.: Do the neural correlates of accupuncture and placebo effects differ? Pain, 2007, 128, 8-12.
13. Atallah, A. N.: Does acupuncture work? Is there any evidence? Sao Paulo Med., 2006, 124, 119-120.
14. Goodman, M., Ro, S., Osapay, G. és mtsai: The molecular basis of opioid potency and selectivity: morphiceptins, dermorphins, deltorphins, and enkephalins. NIDA Res. Monogr., 1993, 134, 195-209.
15. Janecka, A., Staniszewska, R. J. F.: Endomorphin analogs. Curr. Med. Chem., 2007, 14, 3201-3208.
16. Böger, R.: Renal impairment: a challenge for opioid treatment? The role of buprenorphine. Palliat. Med., 2006, 20, 17-23.
17. Yaksh, T. L., Noueihed, R.: The physiology and pharmacology of spinal opiates. Annu. Rev. Pharmacol. Toxicol., 1985, 25, 433-462.
18. Pfeiffer A. A. H.: Endocrine actions of opioids. Horm. Metab. Res., 1984, 16, 386-397.
19. Bowdle, T.: Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf., 1998, 19, 173-189.
20. Panchal, S. J., Müller-Schwefe, P. J. I. W.: Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int. J. Clin. Pract., 2007, 61, 1181-1187.
21. Pattinson, K.: Opioids and the control of respiration. Br. J. Anaesth., 2008, 100, 747-758.
22. Pert, C. B., Snyder, S. H.: Opiate receptor: demonstration in nervous tissue. Science, 1973, 179, 1011-1014.
23. Reisine, T., Bell, G.: Molecular biology of opioid receptors. TINS, 1993, 16, 506-510.
24. Lord, J. A., Waterfield, A. A., Hughes, J. és mtsai: Endogenous opioid peptides: multiple agonists and receptors. Nature, 1977, 267, 495-499.
25. Ling, G. S., Spiegel, K., Lockhart, S. H. és mtsai: Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J. Pharmacol. Exp. Ther., 1985, 232, 149-155.
26. Mansour, A., Khachaturian, H., Lewis, M. E. és mtsai: Anatomy of CNS opioid receptors. Trends Neurosci., 1988, 11, 308-314.
27. Jiang, Z. G., North, R. A.: Pre- and postsynaptic inhibition by opioids in rat striatum. J. Neurosci., 1992, 12, 356-361.
28. Mulder, A. H., Wardeh, G., Hogenboom, F. és mtsai: Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature, 1984, 308, 278-280.
29. North, R. A., Williams, J. T., Surprenant, A. és mtsai: Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA, 1987, 84, 5487-5491.
30. Childers, S. R.: Opioid receptor-coupled second messenger systems. Life Sci., 1991, 48, 1991-2003.
31. Xiao, C., Zhang, L., Cheng, Q. P. és mtsai: The activation of extracellular signal-regulated protein kinase 5 in spinal cord and dorsal root ganglia contributes to inflammatory pain. Brain Res., 2008, 1215, 76-86.
32. Stevens, C.: Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents. Cancer Surv., 1994, 21, 25-47.
33. Chiara, G. D., North, R. A.: Neurobiology of opiate abuse. TIPS, 1992, 13, 185-189.
34. Christie, M. J., Williams, J. T., Osborne, P. B. és mtsai: Where is the locus in opioid withdrawal? TIPS, 1997, 18, 134-140.
35. Lefkowitz, R. J.: G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem., 1998, 273, 18677-18680.
36. Kleber, H.: Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin. Neurosci., 2007, 9, 455-470.